Document is current
Any future updates will be listed below
-
Authors
Woodworth, Joshua S.
Aagaard, Claus
Salguero, Francisco J.
Hunter, Laura
Lindenstrøm, Thomas
Clark, Simon
Mortensen, Rasmus
-
Funding
Funding for this research was provided by:
European Union’s Horizon 2020 research and innovation programme (Grant number: 643381)
National Institute of Allergy and Infectious Diseases (R01AI135721)
NIVI Research Center is supported by The Novo Nordisk Foundation (Grant number: NNF23SA0088562)
- License Information
-
More Information
Article History
Received: 19 March 2026
Accepted: 18 June 2026
First Online: 8 July 2026
Competing interests
: R.M. and C.A. are co-inventors of a patent covering the use of H107 and derivatives. R.M. and J.S.W. are co-inventors of a patent covering the use of the related adjuvant CAF®10b. All rights have been assigned to Statens Serum Institut. The remaining authors declare no competing interests.
